Finding that some patients with Hodgkins Disease and CFS improved their CFS symptoms after Rituximab
immunomodulation by B cell depletion biomedcentral.com/1471-2377... further trials were carried out with larger numbers.
The results of this trial in 2011 ncbi.nlm.nih.gov/pmc/articl... had two positive outcomes, first it improved symptoms for 67% of those involved in the phase two trial, the second positive outcome was an apology from Norways Directorate of Health
Bjørn Guldvog, Deputy Director General of theNorwegian Directorate of Health made the following statement;
"I think that we have not cared for people with ME to a great enough extent. I think it is correct to say that we have not established proper health care services for these people, and I regret that."
The best may yet be ahead of us as stage three trials are underway simmaronresearch.com/2015/0... with the biggest trial that is actually four trials in one.